Damien Bertrand holds a PhD in physics from UCLouvain, Belgium. He has more than 10 years experience in Medical Device industry, with responsibilities in product innovation and strategic partnerships. Since 2017, he is in charge of the Business Development at DNAlytics.
DNAlytics is a Belgian startup proposing innovative data science solutions towards bio-pharmaceutical industry and the healthcare sector. Its expertise proves attractive for applications such as the selection of influencing parameters, the identification and validation of biomarkers, the stratification of subjects, or the prediction of specific outcomes, in particular when the context calls for multi-source data integration and multi-marker combinations. These techniques apply to a variety of contexts in R&D phases, along clinical studies, in bio-manufacturing processes or in the elaboration of healthcare policies.
Next to the service activity, DNAlytics is developing decision-support tools for clinicians : its first product RheumaKit (www.rheumakit.com) is a precision medicine platform in rheumatology, which proposes early differential diagnosis and treatment guidance for rheumatoid arthritis patients.